Cancer Immunotherapy for the General Surgeon. | Am Surg;86(4): 284-292, 2020 Apr 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Cancer Immunotherapy for the General Surgeon.

Fromer, Marc W; Scoggins, Charles R.

Am Surg ; 86(4): 284-292, 2020 Apr 01.

Article in En | MEDLINE | ID: mdl-32391751

Subject(s)

Immunotherapy; Melanoma/drug therapy; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Skin Neoplasms/drug therapy; CTLA-4 Antigen/antagonists & inhibitors; CTLA-4 Antigen/immunology; Carcinoma, Hepatocellular/drug therapy; Carcinoma, Non-Small-Cell Lung/drug therapy; Chemotherapy, Adjuvant; Gastrointestinal Neoplasms/drug therapy; Humans; Immunotherapy/adverse effects; Liver Neoplasms/drug therapy; Programmed Cell Death 1 Receptor/immunology

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Programmed Cell Death 1 Receptor / Immunotherapy / Melanoma Limits: Humans Language: En Journal: Am Surg Year: 2020 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Programmed Cell Death 1 Receptor / Immunotherapy / Melanoma Limits: Humans Language: En Journal: Am Surg Year: 2020 Document type: Article